[1]
2024. Venetoclax and Azacitidine Combination Therapy in Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia. Annals of Leukemia Research. 5, 1 (Nov. 2024), 19–24. DOI:https://doi.org/10.5281/zenodo.22227795.